Could this addicting drug be the ‘next longevity breakthrough’?

Key Points:

• Dave Asprey, founder of the biohacking movement, is drawing attention to research suggesting that oxymetazoline, the active ingredient in Afrin nasal spray, could potentially be repurposed to help maintain youthful and functional cells.
• Researchers at Northeastern University analyzed 6,442 drugs and found oxymetazoline may improve cell-to-cell communication, a biological process that deteriorates with aging and affects immune function, muscle, and bone health.
• Current research on oxymetazoline's effects on cellular communication is ongoing at Harvard, but no human studies have been conducted yet, and scientists caution it is not a cure for aging but a potential avenue for future investigation.
• Aspirin was also identified in the study as a drug that might positively impact multiple aging hallmarks, including intercellular communication, epigenetic alterations, and cell senescence, though its anti-aging effects in humans remain untested.
• Both oxymetazoline and aspirin represent examples of existing, widely available drugs that could offer new strategies for longevity, supporting Asprey's view that the next breakthroughs may come from repurposing known medications rather than developing new molecules.